Search by Drug Name or NDC
NDC 71776-0024-30 Zerviate 2.4 mg/mL Details
Zerviate 2.4 mg/mL
Zerviate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eyevance Pharmaceuticals. The primary component is CETIRIZINE.
MedlinePlus Drug Summary
Cetirizine ophthalmic is used to relieve the itching of allergic pink eye. Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 71776-0024-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cetirizine Ophthalmic
Product Information
| NDC | 71776-0024 |
|---|---|
| Product ID | 71776-024_074ad03b-95e9-7e53-e063-6394a90a0305 |
| Associated GPIs | 86802009102020 |
| GCN Sequence Number | 080791 |
| GCN Sequence Number Description | cetirizine HCl DROPERETTE 0.24 % OPHTHALMIC |
| HIC3 | Q6R |
| HIC3 Description | EYE ANTIHISTAMINES |
| GCN | 47766 |
| HICL Sequence Number | 006544 |
| HICL Sequence Number Description | CETIRIZINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Zerviate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cetirizine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 2.4 |
| Active Ingredient Units | mg/mL |
| Substance Name | CETIRIZINE |
| Labeler Name | Eyevance Pharmaceuticals |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208694 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71776-0024-30 (71776002430)
| NDC Package Code | 71776-024-30 |
|---|---|
| Billing NDC | 71776002430 |
| Package | 30 VIAL, SINGLE-USE in 1 CARTON (71776-024-30) / .2 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2020-03-23 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 7.39367 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ZERVIATE 0.24% EYE DROP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis